In previous reports we have shown that certain nucleoside analogues may be phosphorylated by herpesvirus-specified thymidine kinases, thereby acquiring an ability to act as virus-selective inhibitors of terminal glycosylation. In the present paper we report that the antiviral nucleoside analogue 5-propyl-2'-deoxyuridine induced a pattern of glycosylation inhibition, which resulted in an increased availability of the HSV-1-specified glycoprotein gC-1 for neutralizing antibodies. This effect, which was absent in cells infected with a thymidine kinase-deficient HSV mutant, was correlated with a decrease in the proportion of highly branched N-Iinked oligosaccharides associated with gC-1. Received 
Introduction
Glycosylation inhibitors have been considered for use as antiviralagents because of their ability to inhibit replication of enveloped viruses (Datema et aI., 1987) . To obtain such antiviral effects the inhibitors have to interrupt the glycosylation process at an early step, because there is no evidence that the addition of peripheral carbohydrates is of importance for the formation of infectious virus particles. Recent data suggest that interference with glycosylation could be used for an alternative antiviral strategy by increasing the availability of viral glycoproteins for immune responses. Thus, the branched N-linked oligosaccharides, being constituents of most viral envelope glycoproteins, are highly hydrated and appear as bulky structures, with the ability to cover considerable portions of the protein surface (Montreuil, 1987; Rademacher et aI., 1988) . There is evidence that the structural information for the carbohydrate complement of viral glycoproteins, even for large enveloped viruses such as herpes simplex virus (HSV), results from host enzymes (Campadelli-Fiume and Serafini-Cessi, 1985; Lundstrom et aI., 1987b) . This means that the viral glycoproteins can be shielded by host cell structures, tolerated by immune responses and masking potential neutralizing epitopes, thereby enabling enveloped viruses to escape from immunological clearance. Evidence supporting this function of oligosaccharides has been reported for myxoviruses (Skehel et sl., 1984) and lentiviruses (Huso et al., 1988) .
One major problem is the fact that the interplay between the peptide component of the glycoprotein and the carbohydrate complement is a complex process, involving both positive and negative modulation of the antigenic activity. Thus, prevention of glycosylation with tunicamycin (Kaluza et al., 1980; Merz et al., 1981; Long et al., 1986) , or enzymatic deglycosylation of completely glycosylated proteins (Alexander and Elder, 1984) , in most cases results in loss of the carbohydrate-dependent epitopes of viral glycoproteins. Moreover, even minor changes in the peripheral structures of N-linked oligosaccharides may have consequences for the antigenic activity of glycoproteins. We have shown that the antigenic site II (designation according to Marlin et al. (1985) ) of the HSV-1-specified glycoprotein C (gC-1) increased after removal of terminal sialic acid, whereas further removal of the penultimate galactose residues resulted in complete loss of activity of the site II epitopes (Sjoblom et al., 1987) . All these observations emphasize the necessity to obtain inhibitors which block the glycosylation steps responsible for masking of antigenic activity without a concomitant loss of carbohydrate elements needed by the glycoprotein for acquisition and maintenance of the proper antigenic conformation. To date, most glycosylation inhibitors available act at relatively early steps in the glycosylation process, whereas the carbohydrate determinants responsible for masking of antigenic activity could be suspected of being generated by relatively late-acting enzymes in the medial and trans Golgi region .
By using a new principle for interfering with glycosylation, we have been able to establish a model system for virus-selective blocking of glycosylation steps in the peripheral Golgi regions. Thus, an antiviral agent, the nucleoside analogue (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVdU), which is an inhibitor of DNA synthesis, also acts as an inhibitor of terminal glycosylation specific for HSV-infected cells (Olofsson et al., 1985) . An isolated effect on glycosylation can be achieved when BVdU is added to HSV-infected cells after the peak of DNA synthesis (Olofsson et al., 1985; . The effect on glycosylation is caused by the 5'-monophosphate of BVdU, which is formed in infected cells only by the HSV-specified thymidine kinase. This nucleotide blocks the translocation into the Golgi apparatus of UDP-galactose and CMP-sialic acid, the sugar donors in the galactosyl and slalyl transferase reactions, respectively, thereby inhibiting addition of these sugars to the glycoprotein oligosaccharides (Olofsson et al., 1988) . Using this model system, we show in the present paper that the HSV-selective modification of glycosylation, including a decrease in branching of multi-antennary N-Iinked oligosaccharides, induced by another nucleoside analogue, 5-n-propyl-2'-deoxyuridine (PdU; compound 6 in Fig. 1 ), is associated with a significant incre~se in the antigenic activity of gC-1. These data suggest that it should be possible, in future, to find virus-selective inhibitors that can be used in infected animals and which prevent the addition of peripheral sugars to increase the availability of viral glycoproteins for immune reactions.
ResUlts
As a part of our initial aim of obtaining a structure-function relationship, we tested some other 5-substituted analogues of 2f -deoxyuridine for glycosylation inhibition in HSV-infected cells. We have previously shown that the electrophoretic mobility of gC-1 is a measure ofthe degree of glycosylation of this glycoprotein (Olofsson et aI.,1985) . HSV-1 infected cells were therefore treated with 40 fLM of the compounds indicated in Fig. 1 from 6 hours post infection (pi), to ensure that inhibition of DNA synthesis was not responsible for any differences observed. This is feasible because gC-1 is a'!' protein, not synthesized until after the peak of viral DNA synthesis (Spear, 1985; Wagner, 1985) .
The cells were radiolabelled with ('3Hj-glucosamine (GleN) at 7 h pi and the cells were harvested at 18 h pi and processed for radioimmunoprecipitation and SUbsequent SDS-PAGE. We found that BVdU (serving as a positive control) and 5-n-propyl-2'-deoxyuridine (compound 6; PdU) increased the electrophoretic mobility, indicating partial glycosylation inhibition (Fig. 2) . In contrast, the mobilities of the gC-1 from cells treated with the other substances listed, up to 500 fLM, did not indicate that glycosylation was strongly affected, although small shifts to higher electrophoretic mobilities occasionally were recorded for substances 4 and 7. In conclusion, the bromovinyl and the n-propyl substitutions resulted in more potent inhibitors than did the -CH 20H and -CH = CH-CH 3 substituents. Other closely related substltuents, such as ethyl and -CH 2CH2CI did not result in inhibitors. Since nucleoside analogue monophosphates mediate the inhibitory effect (Olofsson et al., 1988) , the . differences in inhibitory power observed must be due both to the extent of accumulation of monophosphates in infected cells and to the capacity of the monophosphate to inhibit sugar nucleotide translocation. It is known that PdU monophosphate (PdUMP) is formed in HSV-infected cells (Ruth and Cheng, 1982) .
BVdU PdU 100 25 10 100 25 10 a Fig. 2 . SOS-polyacrylamide gel electrophoresis of gC-1 from HSV-1infected cells, treated with increasing concentrations (",g rnr") of BVdU or PdU. The,positions of completely glycosylated gC-1 and the precursor form, containing newly added high-man nose glycans (pgC-1) are indicated. The cells were treated with different concentrations of nucleoside analogues from 6h pi, radiolabelled with ["Hl-GleN at 7h pi and the cells were harvested at 18 h pi and processed for radioimmunoprecipitation and SUbsequent SOS-PAGE. Procedures for radioimmunoprecipitation and electrophoresis have previously been published (Olofsson et aI., 1983) .
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A PdU obtained. at 10-25 /Lg rnr' of BVdU or PdU, and further increase of the drug concentration to 100 /Lg mr' only marginally increased the electrophoretic mobility. It is likely that BVdU and PdU had different modes of inhibition and it was not possible to compensate for this difference by increasing the concentration of PdU.
To compare the effects of BVdU and PdU treatments on the immune reactivity of gC-1 with a polyclonal antiserum, we incubated HSV-infected cells with either BVdU or PdU and labelled them with fHj-GlcN as above. After harvesting and solubilization of cells (Olofsson et al., 1985) , the extract was subjected to precipitation with a polyclonal, neutralizing rabbit antiserum, monospecific for gC-1 (Olofsson et al., 1983) . As a result of (i) low incorporation of amino acid labels into gC-1; and (ii) interfering background levels of nonglycosylated HSV proteins non-specifically precipitated by rabbit IgG, the experiments were carried out with fHj-GlcN-label. Results from two independent series each of BVdU and PdU are depicted ( Fig. 3 , Panel A). Thus, BVdU caused a drastic reduction in the amount of gC-1 available for the antibody. In contrast, PdU-treatment even at high concentrations caused an increase in the amount of gC-1 precipitated by the antiserum. In control experiments, the antigen was diluted two-fold and the antiserum was diluted up to eight-fold with essentially the same results. This effect could be due either to an increased antigenicity of gC-1 produced in the presence of PdU or it could be explained by trivial effects such as a PdU-induced increased biosynthesis of gC-1 or drug-induced asymmetrical incorporation of radiolabelled metabolites into soluble or precipitable cellular pools.
To determine whether the increased amount of gC-1, precipitated with the antiserum, was the result of increased PdU-induced synthesis of gC-1 and other HSV-glycoproteins we subjected Iysates from fHj-GlcNlabelled HSV-infected cultures to SDS-polyacrylamide electrophoresis (Fig. 4) . It was found that the amount of fHj-GlcN in the electrophoretic region containing gC-1 and its precursors was in fact decreased as a consequence of PdU treatment. This reflects decreased incorporation of fHj-GlcN into sialic acid (Olofsson et aI., 1988) . Furthermore, we found no increase in the synthesis of f 5Sj-methionine-labelied glycosylated or non-glycosylated late proteins ( Fig. 5 ), except for one single f 5Sj-methionine-labelied peptide, which obviously did not correspond to any HSV glycoprotein (indicated by an arrow in Fig. 5 ). Consequently, increased synthesis of gC-1 cannot account for the increased amounts of glycoproteins available to the gC-1-specific antibody. We also found that the total incorporation of fHj-GlcN-label into PdU-treated GMK cells decreased after PdU treatment (Table 1) . Moreover, the cell-associated macromolecular pool of fHj-GlcN-label was considerably larger than the A. Radioimmunoprecipitation of gC-1 with a polyclonal antibody, designated K462, with neutralizing activity and monospecific for gC-1 (Olofsson et et., 1983) . Results from two independent experimental series are depicted. B. RCA lectin chromatography gC-1 glycopeptides. Glycoprotein gC·1, derived from the same cultures as analysed in Panel A, was purified by an immunosorbent containing antibody K642 bound to Protein A-Sepharose (Olofsson et a/., 1985) . The glycopeptides were prepared by extensive pronase digestion of purified gC-1. C. Lentil lectin chromatography of similar material as in (B). Materials bounds to RCA and lentil lectin were eluted with 50 mM galactose and a-methyl mannoside, respectively.
BVdU and PdU were examined in more detail by following HSV-infected cells treated with increasing concentrations (up to 100 /Lg rnr') of BVdU and PdU. The BVdU-induced shift in electrophoretic mobility was larger than the one induced by PdU (Fig. 2) . The most prominent part of the shifts caused by both BVdU and PdU was 20 S. Olofsson and R. Datema A B Table 1 . Distribution of rHl-GlcN-label in PdU-treated HSV-1-infected cells. ,.
We next determined whether the increased antigenicity caused by PdU was an HSV-specific process. GMK cells were infected with the TK--strain of HSV and its parent wild-type strain and treated with increasing concentrations of PdU. Extracts from both types of cultures were processed for radioimmunoprecipitation and subsequent SDS-polyacrylamide gel electrophoresis (Fig. 6) . It was found that the PdU treatment caused an increase both in the antigenicity and the electrophoretic mobility of gC-1, produced in wild-type-infected cells, whereas neither antigenicity nor electrophoretical mobility of gC-1 was affected by PdU treatment in cells infected with the TK--strain of HSV. These data demonstrate that phosphorylation of PdU by an HSV-encoded TK is essential for its effects on glycosylation and antigenicity.
The mode of action was investigated by lectin chromatography of glycopeptides of gC-1 obtained by exhaustive pronase digestion of purified gC-1 from rHj-GlcNlabelled HSV-infected cells treated with increasing concentrations of BVdU or PdU (Fig. 3 , Panels B and C). A panel of lectins mainly reacting with determinants of N-Iinked oligosaccharides was used for the chromatography experiments. The rationale for this choice was based on previous observations that treatment of HSVinfected cells with tunicamycin, eliminating all N-linked oligosaccharides but not altering the structures of 0linked oligosaccharides of gC-1 (Lundstrom et aI., 1986a) , resulted in complete disappearance of the carbohydratedependent epitopes (Sjoblom et aI., 1987) . It was found that whereas both BVdU and PdU treatment decreased a. HSV-1-infected cells labelled with 25",Ci of rHl-GlcN from 7 h postinfection and treated with the concentrations of PdU indicated were washed and lysed with TBS, containing 1% (v/v) ofTriton X-100, at 16 h pi. These Iysates were subjected to Sephadex G25 filtration in PO-1O columns. Material migrating with the void volume was considered to be macromolecules and material migrating slower than or together with a [14C]-UOP-galactose marker was regarded as consisting of precursors. pool of rH]-labelled sugar nucleotides and smaller precursors, irrespective of whether the cells were treated with PdU or not (fable 1), indicating that no increase in the specific radioactivity of gC-1 occurred after PdU treatment. Altogether, the results demonstrated that the increased amount of gC-1 from PdU-treated cells, which was precipitated by the polycional antibody, ·wasnotdu8 to trivial factors, such as those described above, but was caused by an increased proportion of the gC-1 fraction binding to the antibody, i.e, an increased antigenicity. the amount of glycopeptides binding to Ricinus communis lectin (RCA) (with main specificity for (31-4-linked Gal; Beanziger and Flete, 1979; Goldstein and Hayes, 1978; Green et sl., 1987) , BVdU but not PdU-treatment decreased the amount of glycopeptides binding to the lentil lectin. This lectin has specificity for moderately branched, mainly bi-antennary, fucosylated complex-type oligosaccharides (Kornfeld et al., 1981) . To further compare the content of branched oligosaccharides between gC-1 from PdU-treated and untreated cells We subjected [3Hj-GlcN-labelled glycopeptides to chromatography on Phaseolus vulqsris leuco-agglutinin (L-PHA), coupled to agarose (Fig. 7) . This lectin retards glycopeptides containing tetra-antennary and certain tri-antennary N-linked oligosaccharides (Cumming and Kornfeld, 1982) . We found that the increase in lentil lectin-binding glycopeptides as a consequence of PdU treatment (Fig. 3, Panel C)was accompanied by a decrease in the amount of L-PHA-retarded glycopeptides, suggesting that PdU treatment caused a shift in formation of complex-type oligosaccharides from tri-and tetra-antennary structures to bi-antennary structures.
Discussion
From the results of the present paper it is possible to conclude that PdU induces a change in protein glycosylation, specific for HSV-infected cells, which is associated with an increase in the antigenic activity of gC-1. The data demonstrate that the effect on antigenicity is correlated with altered glycosylation, and that both these effects are dependent on phosphorylation of PdU by the HSV-1-specified thymidine kinase. BVdU, on the other hand, was not found to increase the antigenicity of gC-1, probably because it blocks addition of terminal sugar residues more strongly than PdU (Olofsson et el., 1988) , leading to loss of carbohydrate determinants engaged in the stabilization of carbohydrate-dependent epitopes (Sjoblom et al., 1987) .
The binding studies with lectins suggest that changes in branching of N-Iinked oligosaccharides may be involved in PdU-induced increases in antigenicity. Thus, the increased antigenicity of gC-1 following PdU-treatment glycopeptides were treated with sialidase in order to compensate for differences in chromatographic behaviour due to differences in sialylation. The chromatography was carried out at room temperature in a column (30 x OAcm) containing L-PHA-Agarose (Sigma, SI. Louis, MO) according to the procedure described by . Prior to L-PHA chromatography, pronase-resistant glycopeptides with clustered O-Iinked oligosaccharides were removed by adsorption to Helix pomatia lectin and peanut lectin, as described by Lundstrom et al. (1986a) .
was associated with differences in oligosaccharide structure, where a decreased degree of galactosylation and branching of N-linked oligosaccharides appear to be important factors. Although galactose contributes to the affinity of oligosaccharides for L-PHA (Cumming and Kornfeld, 1982; , it is unlikely that the increased antigenicity of gC-1 was caused by disappearance of galactose as previous data demonstrate that extensive removal of galactose residues from gC-1 results in a decreased antigenic activity of carbohydratedependent epitopes (Sjoblom et et., 1987) . A decrease in branching of N-linked oligosaccharides is also associated with altered biological properties in an experimental murine tumour system. Thus, elimination of the L-PHAbinding [31-6 branch of complex-type cllqcsaccharides associated with glycoproteins of a highly metastatic cell line results in a dramatic decrease in the metastatic potential (Dennis et et., 1982) .
Using the outlined strategy, it is possible to select for glycosylation inhibitors able to induce exposure of carbohydrate-masked epitopes without inactivating the expression of carbohydrate-dependent epitopes. In this context, PdU, which was synthesized to be a virus-selective inhibitor of DNA synthesis, should be regarded as a lead to substances with more pronounced and specific effects on terminal glycosylation. However, the immediate challenge is to obtain information both on the carbohydrate structures of the N-Iinked oligosaccharides causing selective unmasking as well as those structures responsible for expression of carbohydrate-dependent epitopes. Recent studies in our laboratory, using an excess of gC-1-specific monoclonal antibodies, demonstrated that epitopes may differ in their response to PdU treatment. Thus, the expression of one epitope, defined by a monoclonal antibody with a high neutralizing titre (20000 in a plaque reduction test) was increased at least two-fold by PdU treatment of infected cells, whereas the expression of another which was non-neutralizing, remained unaffected by the treatment (manuscript in preparation). It is therefore important to define the exact nature of the peptide regions harbouring the carbohydrate-dependent epitopes and evaluate whether the PdU-induced increase of antigenicity is a general phenomenon or related specifically to gC-1. In other words, we want to determine whether altered glycosylation induced by PdU in HSV-infected cells increases the antigenicity of the majority of viral glycoproteins with N-linked oligosaccharides. Undoubtedly, PdU will constitute a most valuable tool for obtaining this important information and for clarifying whether interference with glycosylation to improve immunologial properties is worth pursuing as an antiviral strategy.
At present, the mechanism of HSV-selective inhibition of terminal glycosylation hinges on the broad specificity of the HSV-specified thymidine kinase (Olofsson et aI., 1988) . However, in principle it should be possible to 'tailor-make' suitable inhibitors (i) selectively targeted to the sugar nucleotide transport system, and (ii) resulting in increased antigenicity of highly glycosylated proteins also of other viruses, such as gp120, specified by HIV, a glycoprotein in which the carbohydrates comprise 50% of the molecular mass (Allen et aI., 1985; Lifson et aI., 1986) . Demasking of hidden epitopes selectively in virus-infected cells may be a worthwhile antiviral strategy.
Materials and Experimental procedures

Virus and cells
HSV-1 strain F was used for standard experiments whereas the thymidine-kinase deficient strain R9C and its parent wild-type strain (kindly supplied by Dr H. Field, Cambridge, UK) were used in some experiments. African Green Monkey Kidney cells (GMK), strain AH1, were used throughout the study.
Drugs, chemicals and radiochemicals
The origins of the nucleoside analogues are detailed in the legend to Fig. 1 . Used for metabolic labelling of HSV-1-infected cells were D-[6-3Hj-glucosamine hydrochloride (specific activity, 29Ci mmol ") and L-[35Sj-methionine '(specific activity 120mCi rnmor') obtained from Amersham International (UK).All reagents and solvents were of reagent grade.
Radioimmunoprecipitation
Petri dish (50-mm) cultures of GMK-AH1 cells were infected with 10 p.f.u, mr' of HSV-1. The cells were treated with nucleoside analogues from 6h pi, radiolabelled with [3Hj-GlcN at 7h pi and the cells were harvested at 18 h pi. The cells were lysed in 1 ml of tris-buffered saline (TBS) containing 1% Triton X-100 and the nuclei were removed by low-speed centrifugation. The amount of radioactivity precipitable with K462 was determined according to Olofsson et 81. (1983; . The reaction mixture, consisting of 25[L1 of cell extract and 5[L1 of antiserum, was incubated at 4°C for 1 h. Thereafter, 100 [LI of washed staphylococci (10% (v/v) suspension) was added and the mixture was incubated at 4°C for 1 h under gentle agitation. The staphylococci were washed twice in TBS containing 1% Triton X-100 and subsequently twice in TBS without any detergent. Radiolabelled glycoproteins were released from the staphylococci by boiling and d.p.rn, values were calculated after liquid scintillation counting.
Gel filtration
Separation of radiolabelled macromolecules and low molecularweight [3Hj-GlcN-labelied metabolites were carried out in disposable Pharmacia PD-10 Sephadex G25 columns. Soluble extracts, prepared as described above, were applied to the columns, equilibrated with TBS. [14C]-UDp-galactose was used as a label for sugar nucleotides.
Lectin-affinity chromatography
Lectin-affinity chromatography of glycopeptides from purified gC-1 was carried out as previously described (Olofsson et al., 1985) . The pronase digest was inactivated by brief heating to 100°Cand applied to 6-mm-wide mini-columns containing 200 fLl of gel-bound lectins. The following lectins were used: Ricinus communis (RCA), Lentil lectin, and Phaseolus vulgaris leucoagglutinin (L-PHA).
RCA and lentil lectin chromatography. The glycopeptides were allowed to adsorb to the columns, and subsequently the columns were washed thoroughly with TBS and, finally, eluted with solutions of appropriate sugars as indicated in the figure legends. All steps were carried out at 20°C. L-PHAchromatography. The L-PHA chromatography was carried out according to . Sepharose-bound L-PHA was packed in a 40-cm column (inner diameter: 4mm). Pronase-resistant glycopeptides were applied to the column, equilibrated with 0.11 M NaCI in a 0.4 M tris buffer at pH 7.4, and chromatographed at a flow rate of 0.5 ml rnirr ". Fractions of 0.5ml were collected and analysed by liquid scintillation counting.
